| Freedom Hearing Center Llc | |
|
135 W Dares Beach Rd Ste 102, Prince Frederick, MD 20678-3127 | |
| (410) 610-2246 | |
| (443) 432-3943 |
| Full Name | Freedom Hearing Center Llc |
|---|---|
| Type | Facility |
| Speciality | Audiologist |
| Location | 135 W Dares Beach Rd Ste 102, Prince Frederick, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366848947 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 00684 (Maryland) | Primary |
| Provider Name | Becky L Guy |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1780645085 PECOS PAC ID: 3779519368 Enrollment ID: I20050714000814 |
News Archive
Abbott today announced that it has received CE Mark for its new FreeStyle InsuLinx Blood Glucose Monitoring System, the first blood glucose monitoring device from Abbott that includes a mealtime insulin calculator for calculating suggested insulin doses.
Onconova Therapeutics, Inc., announced today the advancement of the oral formulation of rigosertib, an anti-cancer agent with demonstrated activity in solid tumors and hematologic malignancies, into a new Phase II study. The intravenous (IV) formulation of rigosertib is currently in a pivotal Phase III trial for refractory myelodysplastic syndromes (MDS) in the U.S. and EU.
Global Health Partner has acquired OPA, Ortopædisk Privathospital Aarhus A/S in Århus, Denmark, a specialist clinic operating in the fields of orthopaedics and spine surgery.
Components in grapes, including some newly identified ones, work together to dramatically inhibit an enzyme crucial to the proliferation of cancer cells, say scientists at the University of Illinois at Urbana-Champaign.
› Verified 4 days ago
| Provider Name | Lisa R Behringer |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1720187107 PECOS PAC ID: 2961504873 Enrollment ID: I20070223000438 |
News Archive
Abbott today announced that it has received CE Mark for its new FreeStyle InsuLinx Blood Glucose Monitoring System, the first blood glucose monitoring device from Abbott that includes a mealtime insulin calculator for calculating suggested insulin doses.
Onconova Therapeutics, Inc., announced today the advancement of the oral formulation of rigosertib, an anti-cancer agent with demonstrated activity in solid tumors and hematologic malignancies, into a new Phase II study. The intravenous (IV) formulation of rigosertib is currently in a pivotal Phase III trial for refractory myelodysplastic syndromes (MDS) in the U.S. and EU.
Global Health Partner has acquired OPA, Ortopædisk Privathospital Aarhus A/S in Århus, Denmark, a specialist clinic operating in the fields of orthopaedics and spine surgery.
Components in grapes, including some newly identified ones, work together to dramatically inhibit an enzyme crucial to the proliferation of cancer cells, say scientists at the University of Illinois at Urbana-Champaign.
› Verified 4 days ago
| Provider Name | Gina R Diaz |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1265868848 PECOS PAC ID: 7810122553 Enrollment ID: I20131105000154 |
News Archive
Abbott today announced that it has received CE Mark for its new FreeStyle InsuLinx Blood Glucose Monitoring System, the first blood glucose monitoring device from Abbott that includes a mealtime insulin calculator for calculating suggested insulin doses.
Onconova Therapeutics, Inc., announced today the advancement of the oral formulation of rigosertib, an anti-cancer agent with demonstrated activity in solid tumors and hematologic malignancies, into a new Phase II study. The intravenous (IV) formulation of rigosertib is currently in a pivotal Phase III trial for refractory myelodysplastic syndromes (MDS) in the U.S. and EU.
Global Health Partner has acquired OPA, Ortopædisk Privathospital Aarhus A/S in Århus, Denmark, a specialist clinic operating in the fields of orthopaedics and spine surgery.
Components in grapes, including some newly identified ones, work together to dramatically inhibit an enzyme crucial to the proliferation of cancer cells, say scientists at the University of Illinois at Urbana-Champaign.
› Verified 4 days ago
| Provider Name | Rebecca L Jahed |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1225273519 PECOS PAC ID: 2769602564 Enrollment ID: I20140930000072 |
News Archive
Abbott today announced that it has received CE Mark for its new FreeStyle InsuLinx Blood Glucose Monitoring System, the first blood glucose monitoring device from Abbott that includes a mealtime insulin calculator for calculating suggested insulin doses.
Onconova Therapeutics, Inc., announced today the advancement of the oral formulation of rigosertib, an anti-cancer agent with demonstrated activity in solid tumors and hematologic malignancies, into a new Phase II study. The intravenous (IV) formulation of rigosertib is currently in a pivotal Phase III trial for refractory myelodysplastic syndromes (MDS) in the U.S. and EU.
Global Health Partner has acquired OPA, Ortopædisk Privathospital Aarhus A/S in Århus, Denmark, a specialist clinic operating in the fields of orthopaedics and spine surgery.
Components in grapes, including some newly identified ones, work together to dramatically inhibit an enzyme crucial to the proliferation of cancer cells, say scientists at the University of Illinois at Urbana-Champaign.
› Verified 4 days ago
| Provider Name | Sarah Draper Tellier |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1154666550 PECOS PAC ID: 7416187851 Enrollment ID: I20210524001874 |
News Archive
Abbott today announced that it has received CE Mark for its new FreeStyle InsuLinx Blood Glucose Monitoring System, the first blood glucose monitoring device from Abbott that includes a mealtime insulin calculator for calculating suggested insulin doses.
Onconova Therapeutics, Inc., announced today the advancement of the oral formulation of rigosertib, an anti-cancer agent with demonstrated activity in solid tumors and hematologic malignancies, into a new Phase II study. The intravenous (IV) formulation of rigosertib is currently in a pivotal Phase III trial for refractory myelodysplastic syndromes (MDS) in the U.S. and EU.
Global Health Partner has acquired OPA, Ortopædisk Privathospital Aarhus A/S in Århus, Denmark, a specialist clinic operating in the fields of orthopaedics and spine surgery.
Components in grapes, including some newly identified ones, work together to dramatically inhibit an enzyme crucial to the proliferation of cancer cells, say scientists at the University of Illinois at Urbana-Champaign.
› Verified 4 days ago
| Provider Name | Lauralee O Chylinski |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1669146080 PECOS PAC ID: 2961894811 Enrollment ID: I20220126002181 |
News Archive
Abbott today announced that it has received CE Mark for its new FreeStyle InsuLinx Blood Glucose Monitoring System, the first blood glucose monitoring device from Abbott that includes a mealtime insulin calculator for calculating suggested insulin doses.
Onconova Therapeutics, Inc., announced today the advancement of the oral formulation of rigosertib, an anti-cancer agent with demonstrated activity in solid tumors and hematologic malignancies, into a new Phase II study. The intravenous (IV) formulation of rigosertib is currently in a pivotal Phase III trial for refractory myelodysplastic syndromes (MDS) in the U.S. and EU.
Global Health Partner has acquired OPA, Ortopædisk Privathospital Aarhus A/S in Århus, Denmark, a specialist clinic operating in the fields of orthopaedics and spine surgery.
Components in grapes, including some newly identified ones, work together to dramatically inhibit an enzyme crucial to the proliferation of cancer cells, say scientists at the University of Illinois at Urbana-Champaign.
› Verified 4 days ago
| Provider Name | Rivkah Nakhon |
|---|---|
| Provider Type | Practitioner - Qualified Audiologist |
| Provider Identifiers | NPI Number: 1710607007 PECOS PAC ID: 1658745054 Enrollment ID: I20230327001985 |
News Archive
Abbott today announced that it has received CE Mark for its new FreeStyle InsuLinx Blood Glucose Monitoring System, the first blood glucose monitoring device from Abbott that includes a mealtime insulin calculator for calculating suggested insulin doses.
Onconova Therapeutics, Inc., announced today the advancement of the oral formulation of rigosertib, an anti-cancer agent with demonstrated activity in solid tumors and hematologic malignancies, into a new Phase II study. The intravenous (IV) formulation of rigosertib is currently in a pivotal Phase III trial for refractory myelodysplastic syndromes (MDS) in the U.S. and EU.
Global Health Partner has acquired OPA, Ortopædisk Privathospital Aarhus A/S in Århus, Denmark, a specialist clinic operating in the fields of orthopaedics and spine surgery.
Components in grapes, including some newly identified ones, work together to dramatically inhibit an enzyme crucial to the proliferation of cancer cells, say scientists at the University of Illinois at Urbana-Champaign.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Freedom Hearing Center Llc 135 W Dares Beach Rd Ste 102, Prince Frederick, MD 20678-3127 Ph: (443) 295-7100 | Freedom Hearing Center Llc 135 W Dares Beach Rd Ste 102, Prince Frederick, MD 20678-3127 Ph: (410) 610-2246 |
News Archive
Abbott today announced that it has received CE Mark for its new FreeStyle InsuLinx Blood Glucose Monitoring System, the first blood glucose monitoring device from Abbott that includes a mealtime insulin calculator for calculating suggested insulin doses.
Onconova Therapeutics, Inc., announced today the advancement of the oral formulation of rigosertib, an anti-cancer agent with demonstrated activity in solid tumors and hematologic malignancies, into a new Phase II study. The intravenous (IV) formulation of rigosertib is currently in a pivotal Phase III trial for refractory myelodysplastic syndromes (MDS) in the U.S. and EU.
Global Health Partner has acquired OPA, Ortopædisk Privathospital Aarhus A/S in Århus, Denmark, a specialist clinic operating in the fields of orthopaedics and spine surgery.
Components in grapes, including some newly identified ones, work together to dramatically inhibit an enzyme crucial to the proliferation of cancer cells, say scientists at the University of Illinois at Urbana-Champaign.
› Verified 4 days ago
Roraine Kleist, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 131 Main St Ste 202, Prince Frederick, MD 20678 Phone: 410-535-6975 Fax: 410-535-6915 | |
Dr. Rebecca Lynn Jahed, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 3180 Blackberry Lane, Prince Frederick, MD 20678 Phone: 410-610-2246 | |
Dr. Gina Rose Diaz, Audiologist Medicare: Accepting Medicare Assignments Practice Location: 135 W Dares Beach Rd Ste 102, Prince Frederick, MD 20678 Phone: 443-295-7100 Fax: 443-295-7555 | |
Dr. Danielle Glenn Corbin, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 131 Main St Ste 202, Prince Frederick, MD 20678 Phone: 410-535-6975 Fax: 410-535-6915 | |
Dr. Barbara Jarboe Brunner, AUD, CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1305 Dares Beach Rd, Prince Frederick, MD 20678 Phone: 443-550-8345 | |
Beth Valerie Nelson, M.A., CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1305 Dares Beach Rd, Prince Frederick, MD 20678 Phone: 443-550-8345 |